Targeting breast cancer metabolism with a novel inhibitor of mitochondrial ATP synthesis

Overview of attention for article published in Oncotarget, October 2020

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
Above-average Attention Score compared to outputs of the same age and source (62nd percentile)

So far, Altmetric has seen 3 news stories from 3 outlets.

The Oncotarget author’s data suggest in vitro proof-of-concept that supports inhibition of mitochondrial ATP synthase and ROS…

The Oncotarget author’s data suggest in vitro proof-of-concept that supports inhibition of mitochondrial ATP synthase and ROS…

The cover for Issue 44 of Oncotarget features Figure 1, "Inhibitory effect of CADD522 on mitochondrial OCR," recently published…